Jason Fredette | Senior Vice President, Investor Relations and Corporate Communications |
Anna Protopapas | President, CEO & Director |
Arvin Yang | Senior VP & Chief Medical Officer |
Tim Lowinger | Chief Science & Technology Officer |
Brian DeSchuytner | Senior VP & CFO |
Jonathan Chang | SVB Leerink |
Boris Peaker | Cowen |
Daniel Wolle | JPMorgan |
Colleen Kusy | Baird |
David Nierengarten | Wedbush Securities |
Good morning, and welcome to Mersana Therapeutics First Quarter 2022 Conference Call and webcast. Currently all participants are in a listen-only mode. There will be a question answer session at the end of this call. I would now like to turn the call over to Jason Fredette, Senior Vice President, Investor Relations and Corporate Communications. Please proceed.